Opendata, web and dolomites

MABIOS SIGNED

The first microalgae platform for the production of anticancer biopharmaceuticals

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MABIOS project word cloud

Explore the words cloud of the MABIOS project. It provides you a very rough idea of what is the project "MABIOS" about.

scalable    active    proof    patient    dutch    rate    limited    price    anticancer    companies    regulatory    lower    consuming    opportunity    cell    overview    genetically    yield    peptides    engineered    purification    biomanufacturing    manufacture    small    showcase    patients    requiring    solid    platform    algae    cultivation    market    difficult    business    biopharmaceutical    agents    biopharmaceuticals    tumours    treatment    frontrunner    meet    cancer    start    first    de    unmet    biorefinery    starting    organisms    lines    yields    biorefineries    microalgae    recombinant    line    time    ease    clear    affordable    ingredients    mabios    formulate    enter    drastic    utilizing    world    investor    pharmaceutical    manufacturing    sold    urgent    utilize    mission    revolutionize    works    create    risked    molecules    living    roadmap    micro    oncologic    plan    advantages    drugs    demand    therapeutic    obstacles    proteins    treatments    photosynthetic    expensive    paclitaxel   

Project "MABIOS" data sheet

The following table provides information about the project.

Coordinator
MICROALGAE WORKS BV 

Organization address
address: BARGELAAN 200
city: LEIDEN
postcode: 2333 CW
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MICROALGAE WORKS BV NL (LEIDEN) coordinator 50˙000.00

Map

 Project objective

Manufacturing costs remain one of the major obstacles to providing effective treatment of cancer patients. Anticancer agents are often complex biopharmaceuticals that are expensive to manufacture, requiring use of living cell lines with difficult-to-control production processes, limited yields and time-consuming purification steps. There is an urgent unmet need for an improved manufacturing process of biopharmaceuticals, to meet the high demand and lower the price of oncologic treatments. We will revolutionize the way biopharmaceuticals are produced by developing a microalgae based biorefinery platform. These biorefineries will utilize genetically engineered microalgae to efficiently produce pharmaceutical agents. Microalgae are photosynthetic micro-organisms that have unique advantages as biopharmaceutical production systems, including high growth rate, ease of cultivation and low growth costs, enabling cost effective and scalable yield of active ingredients. These will be recombinant proteins, small molecules or therapeutic peptides, starting with Paclitaxel as showcase, one of the world’s best sold anticancer drugs used as the first line treatment of a several solid tumours. Our platform has the potential to become the new manufacturing method of choice for production of highly needed biopharmaceuticals. Microalgae Works is an ambitious Dutch start-up with the mission to make anticancer treatment affordable for every patient through a drastic reduction of manufacturing costs. We are supported by leading companies in the field of biomanufacturing. The MABIOS project will (1) create a clear overview of the market opportunity for micro-algae based production of paclitaxel, (2) develop a de-risked plan for the technical development of our platform, (3) evaluate the necessary regulatory roadmap to enter the market, and (4) formulate an investor-proof business plan. We aim to become the frontrunner in biopharmaceutical production utilizing microalgae.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MABIOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MABIOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

TOM-E (2019)

TOM-E is the first GPS navigation device that is the less expensive on the market and multimodal. With Tom-E, riding has never been easier.

Read More